Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 9.995 USD 1.16%
Market Cap: 144.1m USD

Intrinsic Value

The intrinsic value of one ANIK stock under the Base Case scenario is 25.896 USD. Compared to the current market price of 9.995 USD, Anika Therapeutics Inc is Undervalued by 61%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ANIK Intrinsic Value
25.896 USD
Undervaluation 61%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Anika Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ANIK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ANIK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Anika Therapeutics Inc.

Explain Valuation
Compare ANIK to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ANIK?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Anika Therapeutics Inc

Current Assets 99.3m
Cash & Short-Term Investments 53.2m
Receivables 24m
Other Current Assets 22.2m
Non-Current Assets 88.4m
PP&E 65.8m
Intangibles 9.7m
Other Non-Current Assets 12.8m
Efficiency

Free Cash Flow Analysis
Anika Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Anika Therapeutics Inc

Revenue
123.7m USD
Cost of Revenue
-53.4m USD
Gross Profit
70.3m USD
Operating Expenses
-81.2m USD
Operating Income
-10.9m USD
Other Expenses
-49.7m USD
Net Income
-60.6m USD
Fundamental Scores

ANIK Profitability Score
Profitability Due Diligence

Anika Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Declining Gross Margin
26/100
Profitability
Score

Anika Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ANIK Solvency Score
Solvency Due Diligence

Anika Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
74/100
Solvency
Score

Anika Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANIK Price Targets Summary
Anika Therapeutics Inc

Wall Street analysts forecast ANIK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIK is 16.32 USD with a low forecast of 16.16 USD and a high forecast of 16.8 USD.

Lowest
Price Target
16.16 USD
62% Upside
Average
Price Target
16.32 USD
63% Upside
Highest
Price Target
16.8 USD
68% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Anika Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ANIK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ANIK Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ANIK stock?

The intrinsic value of one ANIK stock under the Base Case scenario is 25.896 USD.

Is ANIK stock undervalued or overvalued?

Compared to the current market price of 9.995 USD, Anika Therapeutics Inc is Undervalued by 61%.

Back to Top